Russian President Vladimir Putin announced on Wednesday that Russian scientists are on the verge of developing vaccines for cancer, offering potential breakthroughs for patients in the near future.
Speaking during a Moscow forum on future technologies, Putin shared in televised comments, stating, “We have come very close to the creation of so-called cancer vaccines and immunomodulatory drugs of a new generation.”
He expressed hope that these advancements would soon become effective methods for individualized therapy.
In a notable collaboration, the UK government signed an agreement with Germany-based BioNTech last year to initiate clinical trials for “personalized cancer treatments,” aiming to benefit 10,000 patients by 2030.
In the pharmaceutical sector, companies like Moderna and Merck & Co are making strides with an experimental cancer vaccine. A mid-stage study demonstrated promising results, showing a 50% reduction in the risk of recurrence or death from melanoma, the most lethal form of skin cancer, after three years of treatment.
Additionally, the World Health Organization notes the existence of six licensed vaccines targeting human papillomaviruses (HPV), which are linked to various cancers, including cervical cancer. Vaccines against hepatitis B (HBV), a virus associated with liver cancer, are also available.
